4//SEC Filing
ROBIN HOWARD W 4
Accession 0000950170-25-113691
CIK 0000906709other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 8:31 PM ET
Size
17.2 KB
Accession
0000950170-25-113691
Insider Transaction Report
Form 4
ROBIN HOWARD W
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-09-04$33.54/sh−1,496$50,176→ 64,421 total - Sale
Common Stock
2025-09-05$39.89/sh−1,136$45,315→ 56,008 total - Sale
Common Stock
2025-09-04$32.37/sh−1,923$62,248→ 65,917 total - Sale
Common Stock
2025-09-04$34.40/sh−613$21,087→ 63,808 total - Sale
Common Stock
2025-09-05$37.87/sh−3,304$125,122→ 59,370 total - Sale
Common Stock
2025-09-04$35.80/sh−1,134$40,597→ 62,674 total - Sale
Common Stock
2025-09-05$38.82/sh−2,226$86,413→ 57,144 total
Holdings
- 28(indirect: By Spouse)
Common Stock
Footnotes (8)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $32.01 to $32.99 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F3]This transaction was executed in multiple trades at prices ranging from $33.02 to $33.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F4]This transaction was executed in multiple trades at prices ranging from $34.05 to $34.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F5]This transaction was executed in multiple trades at prices ranging from $35.35 to $36.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F6]This transaction was executed in multiple trades at prices ranging from $37.50 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F7]This transaction was executed in multiple trades at prices ranging from $38.50 to $39.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F8]This transaction was executed in multiple trades at prices ranging from $39.50 to $40.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001206869
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 8:31 PM ET
- Size
- 17.2 KB